Deals1 Oct 2025, 12:02 pm
Aurobindo Pharma Completes Share Transfer Among Subsidiaries
AI Summary
Aurobindo Pharma Ltd. has completed the transfer of shares from Helix Healthcare B.V. to Curateq Biologics B.V., both wholly owned subsidiaries of the company. The transfer of the entire shares of CuraTeQ Biologics s.r.o., held by Helix Healthcare B.V., to Curateq Biologics B.V., was confirmed by the local authority of Czech Republic on September 30, 2025. This share transfer resulted in CuraTeQ Biologics s.r.o. ceasing to be a wholly owned subsidiary of Helix Healthcare B.V and becoming a wholly owned subsidiary of Curateq Biologics B.V.
Key Highlights
- Aurobindo Pharma Ltd. has completed the transfer of shares among its subsidiaries.
- The transfer involved Helix Healthcare B.V. and Curateq Biologics B.V., both wholly owned subsidiaries of Aurobindo Pharma Ltd.
- CuraTeQ Biologics s.r.o., previously a subsidiary of Helix Healthcare B.V., is now a subsidiary of Curateq Biologics B.V.
- The share transfer has been confirmed by the local authority of Czech Republic.
- This deal marks a significant development in Aurobindo Pharma Ltd.'s subsidiary structure.